Since BRD4 degradation impacts Notch1, Myc, CD44, cellular ROS, and cell homing (migration); all of which are critical for T-ALL biology and LIC maintenance, we hypothesized that ARV-825 would be effective as a single agent in treating T-ALL. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.